SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990.Right pointing arrow large image Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public Inspection
Name of the organization
FRED HUTCHINSON CANCER RESEARCH CENTER
 
Employer identification number

23-7156071
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in the region (d) Activities conducted in region (by type) (such as, fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in the region		 (f) Total expenditures
for and investments
in the region
EAST ASIA AND THE PACIFIC 0 0 GRANT MAKING N/A 78,000
EUROPE (INCLUDING ICELAND AND GREENLAND) 0 0 GRANT MAKING N/A 1,122,000
NORTH AMERICA 0 0 GRANT MAKING N/A 2,769,000
SOUTH AMERICA 0 0 GRANT MAKING N/A 11,728,000
SUB-SAHARAN AFRICA 0 0 GRANT MAKING N/A 29,674,163
CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES RESEARCH 3,000
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES RESEARCH 108,000
EUROPE (INCLUDING ICELAND AND GREENLAND) 0 0 PROGRAM SERVICES RESEARCH 1,362,000
MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES RESEARCH 3,000
NORTH AMERICA 0 0 PROGRAM SERVICES RESEARCH 784,000
SOUTH AMERICA 0 0 PROGRAM SERVICES RESEARCH 315,000
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES RESEARCH 5,710,000
CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESMENTS N/A 1,375,131
           
           
           
           
3a Sub-total .... 0 0 46,844,163
b Total from continuation sheets to Part I ... 0 0 8,187,131
c Totals (add lines 3a and 3b) 0 0 55,031,294
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2021
Schedule F (Form 990) 2021
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of noncash
assistance 		(h) Description
of noncash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 2,471,892 WIRE TRANSFER 0    
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 2,354,117 WIRE TRANSFER 0    
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 1,196,516 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 3,058,753 WIRE TRANSFER 0    
NORTH AMERICA PUBLIC HEALTH SCIENCES 23,233 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 13,862 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 640,326 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 118,265 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 1,144,621 WIRE TRANSFER 0    
NORTH AMERICA HUMAN BIOLOGY 43,200 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) VACCINE AND INFECTIOUS DISEASE 41,999 WIRE TRANSFER 0    
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 2,502,404 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) HUMAN BIOLOGY 48,935 CHECK 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 41,586 WIRE TRANSFER 0    
NORTH AMERICA VACCINE AND INFECTIOUS DISEASE 416,256 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 1,971,543 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) PUBLIC HEALTH SCIENCES 117,094 WIRE TRANSFER 0    
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 10,766 WIRE TRANSFER 0    
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 437,054 WIRE TRANSFER 0    
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 772,902 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) PUBLIC HEALTH SCIENCES 47,590 WIRE TRANSFER 0    
NORTH AMERICA VACCINE AND INFECTIOUS DISEASE 1,135,745 WIRE TRANSFER 0    
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 5,419 WIRE TRANSFER 0    
NORTH AMERICA CLINICAL RESEARCH 37,791 CHECK 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) VACCINE AND INFECTIOUS DISEASE 123,395 CHECK 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 70,654 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) PUBLIC HEALTH SCIENCES 18,948 CHECK 0    
SOUTH AMERICA VACCINE AND INFECTIOUS DISEASE 1,976,942 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) PUBLIC HEALTH SCIENCES 48,293 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA PUBLIC HEALTH SCIENCES 18,994 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 2,369,621 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 883,170 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) HUMAN BIOLOGY 162,050 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 176,634 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) CLINICAL RESEARCH 316,919 CHECK 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 307,677 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 1,690,524 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 2,939,031 WIRE TRANSFER 0    
NORTH AMERICA VACCINE AND INFECTIOUS DISEASE 421,064 WIRE TRANSFER 0    
NORTH AMERICA VACCINE AND INFECTIOUS DISEASE 400,624 CHECK 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) PUBLIC HEALTH SCIENCES 55,550 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) PUBLIC HEALTH SCIENCES 31,743 CHECK 0    
SUB-SAHARAN AFRICA PUBLIC HEALTH SCIENCES 5,937 WIRE TRANSFER 0    
EAST ASIA AND THE PACIFIC PUBLIC HEALTH SCIENCES 40,440 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 30,164 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 1,828,393 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 1,062,095 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 1,550,382 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 2,310,739 WIRE TRANSFER 0    
NORTH AMERICA VACCINE AND INFECTIOUS DISEASE 55,044 CHECK 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 752,169 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 313,653 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA CLINICAL RESEARCH 74,928 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) PUBLIC HEALTH SCIENCES 54,608 WIRE TRANSFER 0    
EUROPE (INCLUDING ICELAND AND GREENLAND) PUBLIC HEALTH SCIENCES 54,608 CHECK 0    
NORTH AMERICA CLINICAL RESEARCH 236,109 CHECK 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 1,578,119 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 19,341 CHECK 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 70,654 WIRE TRANSFER 0    
EAST ASIA AND THE PACIFIC PUBLIC HEALTH SCIENCES 38,003 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 858,308 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 3,667,331 WIRE TRANSFER 0    
SUB-SAHARAN AFRICA VACCINE AND INFECTIOUS DISEASE 107,163 WIRE TRANSFER 0    
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......MediumBullet
59
3 Enter total number of other organizations or entities .......................MediumBullet
0
Schedule F (Form 990) 2021
Schedule F (Form 990) 2021Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
noncash
assistance 		(g) Description
of noncash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2021
Schedule F (Form 990) 2021
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule F (Form 990) 2021
Schedule F (Form 990) 2021
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information. See instructions.
ReturnReference Explanation
PART I, LINE 2: SOME GRANTS RECEIVED BY FHCRC ARE PASSED ON TO SUBRECIPIENTS, IN ALL OR IN PART. ONCE THE NOTICE OF AWARD HAS BEEN RECEIVED FOR THE PRIME AWARD, FHCRC SETS UP A SUBAWARD. AN INDIVIDUAL KNOWN AS A RESEARCH COORDINATOR (RC) IS ASSIGNED TO CLOSELY MONITOR ALL SUBAWARD ACTIVITY. THERE ARE 4 PRIMARY STEPS IN THIS PROCESS: (1) A COPY OF THE PRIME AWARD, THE SIGNED SUBAWARD APPLICATION (IF AVAILABLE) AND ANY SPECIAL INSTRUCTIONS ARE MAINTAINED. A SIGNED SUBAWARD APPLICATION SHOWS THAT THE SUBRECIPIENT ORGANIZATION HAS REVIEWED AND APPROVED THE BUDGET AND SCOPE OF WORK. (2) THE RC PREPARES A FORM THAT PROVIDES AUTHORIZATION TO ISSUE THE SUBAWARD, AND INCLUDES A SCOPE OF WORK, BUDGET, AND ANY PERTINENT SUBRECIPIENT INFORMATION. (3) INFORMATION IS COLLECTED TO SET UP THE SUBAWARD IN THE ACCOUNTING SYSTEM, INCLUDING INSTITUTIONAL REVIEW OFFICE APPROVAL, INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE APPROVAL DATES, CONFIRMATION OF SUBAWARD FACILITIES AND ADMINISTRATIVE RATES AND A-133 OR UNIFORM GUIDANCE AUDIT REPORTS, REVIEW OF PRIME SPECIAL TERMS AND CONDITIONS TO DETERMINE FLOW-DOWN, CONFIRMATION THAT THE SUBRECIPIENT IS NOT DEBARRED, AND OTHER SIMILAR REGULATORY AND ADMINISTRATIVE REQUIREMENTS. FOR FOREIGN VENDORS, WE REQUIRE A COMPLETED W-8-BEN-E AND WE RUN THEIR LEGAL NAME THROUGH EXPORT.GOV. (4) THE SUBAWARD AGREEMENT IS COMPLETED AND MAILED TO THE SUBRECIPIENT FOR REVIEW OF TERMS AND CONDITIONS, APPLICABLE INSTITUTIONAL DESIGNATION, FEDERAL CONFLICT OF INTEREST, AND SIGNATURE. THE RC MAINTAINS A COPY OF THE FULLY SIGNED AGREEMENT. NO PAYMENTS ARE MADE TO THE SUBRECIPIENT UNTIL FHCRC RECEIVES THE FULLY EXECUTED AGREEMENT.
PART I, LINE 3: THE CASH METHOD WAS USED IN ACCOUNTING FOR EXPENDITURES IN PARTS I AND II.
PART III ACCOUNTING METHOD:  
PART IV, LINE 1: FORM 926 IS NOT REQUIRED TO BE FILED BECAUSE THE TRANSFER TO A FOREIGN CORPORATION DOES NOT MEET THE REPORTING REQUIREMENTS IN THE IRC SEC 6038(A)(1)(A).
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2021
Additional Data


Software ID:  
Software Version: